• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-烷基-3-(1,2,3,6-四氢吡啶-4-基)-1H-吲哚作为新型5-HT6受体激动剂。

2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.

作者信息

Mattsson Cecilia, Sonesson Clas, Sandahl Anna, Greiner Hartmut E, Gassen Michael, Plaschke Jörg, Leibrock Joachim, Böttcher Henning

机构信息

Medicinal Chemistry, Carlsson Research AB, Biotech Center, Arvid Wallgrens Backe 20, SE-413 46 Goteborg, Sweden.

出版信息

Bioorg Med Chem Lett. 2005 Oct 1;15(19):4230-4. doi: 10.1016/j.bmcl.2005.06.067.

DOI:10.1016/j.bmcl.2005.06.067
PMID:16055331
Abstract

A series of 2-alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles were synthesized and evaluated for their 5-HT6 activity. The most potent agonist in this series was 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole with an IC50=7.4 nM in 3H-LSD binding and an EC50=1.0 nM in a functional assay measuring production of cyclic AMP.

摘要

合成了一系列2-烷基-3-(1,2,3,6-四氢吡啶-4-基)-1H-吲哚,并对其5-HT6活性进行了评估。该系列中最有效的激动剂是5-氯-2-甲基-3-(1,2,3,6-四氢吡啶-4-基)-1H-吲哚,在3H-LSD结合实验中的IC50 = 7.4 nM,在测量环磷酸腺苷生成的功能实验中的EC50 = 1.0 nM。

相似文献

1
2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.2-烷基-3-(1,2,3,6-四氢吡啶-4-基)-1H-吲哚作为新型5-HT6受体激动剂。
Bioorg Med Chem Lett. 2005 Oct 1;15(19):4230-4. doi: 10.1016/j.bmcl.2005.06.067.
2
Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.5-氯-2-甲基-3-(1,2,3,6-四氢吡啶-4-基)-1H-吲哚类似物作为 5-HT(6)受体激动剂的构效关系。
Eur J Med Chem. 2013 May;63:578-88. doi: 10.1016/j.ejmech.2013.03.006. Epub 2013 Mar 14.
3
N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.N1-芳基磺酰基-3-(1,2,3,6-四氢吡啶-4-基)-1H-吲哚衍生物是强效且选择性的5-HT6受体拮抗剂。
Bioorg Med Chem Lett. 2005 Jan 17;15(2):379-83. doi: 10.1016/j.bmcl.2004.10.064.
4
Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.新型1-(氮杂环基)-3-芳基磺酰基-1H-吡咯并[2,3-b]吡啶作为5-HT6激动剂和拮抗剂。
Bioorg Med Chem. 2007 Sep 15;15(18):6208-26. doi: 10.1016/j.bmc.2007.06.024. Epub 2007 Jun 14.
5
Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.2-吡啶甲胺的新型衍生物作为5-羟色胺1A受体的选择性、强效且口服活性激动剂。
J Med Chem. 1999 May 6;42(9):1648-60. doi: 10.1021/jm9806906.
6
Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.作为5-HT6受体拮抗剂的构象受限N1-芳基磺酰基色胺衍生物。
Bioorg Med Chem Lett. 2005 Nov 1;15(21):4780-5. doi: 10.1016/j.bmcl.2005.07.028.
7
3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.3-(芳基磺酰基)-1-(氮杂环烷基)-1H-吲哚是 5-HT(6)受体调节剂。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1657-60. doi: 10.1016/j.bmcl.2010.01.073. Epub 2010 Jan 21.
8
Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.发现5-芳基磺酰胺基-3-(吡咯烷-2-基甲基)-1H-吲哚衍生物作为强效、选择性5-羟色胺6受体激动剂和拮抗剂。
J Med Chem. 2005 Jan 27;48(2):353-6. doi: 10.1021/jm049243i.
9
8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.8-磺酰基取代的四氢-1H-吡啶并[4,3-b]吲哚作为 5-HT6 受体拮抗剂。
Eur J Med Chem. 2010 Feb;45(2):782-9. doi: 10.1016/j.ejmech.2009.10.035. Epub 2009 Oct 31.
10
3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
J Med Chem. 1999 Feb 25;42(4):691-705. doi: 10.1021/jm980569z.

引用本文的文献

1
WAY-208466, a 5-HT receptor agonist, increases food motivation in primates: A behavioural and PET imaging study opening perspectives in eating disorders.WAY-208466,一种5-羟色胺受体激动剂,可增强灵长类动物的进食动机:一项行为学和正电子发射断层扫描成像研究为饮食失调研究开辟了新视角。
Neurosci Appl. 2024 Aug 3;3:104086. doi: 10.1016/j.nsa.2024.104086. eCollection 2024.
2
The Synthesis and Absolute Configuration of Enantiomeric Pure (R)- and (S)-3-(piperidin-3-yl)-1H-Indole Derivatives.(R)-和(S)-3-(哌啶-3-基)-1H-吲哚衍生物的立体纯对映异构体的合成与绝对构型。
Int J Mol Sci. 2022 Dec 28;24(1):517. doi: 10.3390/ijms24010517.
3
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
国际基础和临床药理学联合会。CX. 5-羟色胺受体分类:药理学与功能。
Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552.
4
The 5-HT Receptors in the Ventrolateral Orbital Cortex Attenuate Allodynia in a Rodent Model of Neuropathic Pain.腹外侧眶额皮质中的5-羟色胺受体减轻神经性疼痛啮齿动物模型中的痛觉过敏。
Front Neurosci. 2020 Aug 18;14:884. doi: 10.3389/fnins.2020.00884. eCollection 2020.
5
Study on the effect of EMD386088, a 5-HT receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats.研究 5-HT 受体部分激动剂 EMD386088 增强某些抗抑郁药在大鼠中的抗不动作用。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Jan;391(1):37-49. doi: 10.1007/s00210-017-1431-y. Epub 2017 Oct 27.
6
Metabolic and Cardiovascular Benefits and Risks of EMD386088-A 5-HT Receptor Partial Agonist and Dopamine Transporter Inhibitor.EMD386088(一种5-羟色胺受体部分激动剂和多巴胺转运体抑制剂)的代谢及心血管方面的益处与风险
Front Neurosci. 2017 Feb 8;11:50. doi: 10.3389/fnins.2017.00050. eCollection 2017.
7
Serotonin 5-HT Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.5-羟色胺5-羟色胺受体拮抗剂在阿尔茨海默病中的应用:治疗原理及当前发展状况
CNS Drugs. 2017 Jan;31(1):19-32. doi: 10.1007/s40263-016-0399-3.
8
Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.对5-羟色胺6型(5-HT6)部分激动剂EMD 386088在大鼠体内潜在抗抑郁活性作用机制的研究。
Naunyn Schmiedebergs Arch Pharmacol. 2016 Aug;389(8):839-49. doi: 10.1007/s00210-016-1245-3. Epub 2016 Apr 23.
9
Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats.5-羟色胺6受体部分激动剂EMD 386088对大鼠进行急性和慢性全身给药后的抗抑郁样活性。
Naunyn Schmiedebergs Arch Pharmacol. 2015 Oct;388(10):1079-88. doi: 10.1007/s00210-015-1141-2. Epub 2015 Jun 16.
10
Activation of 5-HT6 receptors modulates sleep-wake activity and hippocampal theta oscillation.5-HT6 受体的激活调节睡眠-觉醒活动和海马θ振荡。
ACS Chem Neurosci. 2013 Jan 16;4(1):191-9. doi: 10.1021/cn300184t. Epub 2012 Dec 10.